Neuroscientist Stanley Rapoport hasn’t had much luck with his co-authors.
Recently, we’ve reported on multiple retractions of papers co-authored by Rapoport after three different first authors were found to have committed misconduct. Now, the fallout from one of those cases had led to four more retractions, bringing Rapoport’s total to 12.
The latest batch of retractions stem from the actions of Jagadeesh Rao.
Here’s the first notice, issued by Psychopharmacology:
The National Institutes of Health has found that Dr. Jagadeesh S. Rao engaged in research misconduct by falsifying data in this article. Data in in Figures 4A-B were falsified. Therefore, Dr. Stanley I. Rapoport has requested a full retraction.
“Chronic fluoxetine increases cytosolic phospholipase A2 activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat” has been cited 30 times since it was published in 2007, according to Clarivate Analytics’ Web of Science, formerly part of Thomson Reuters.
Here’s the second notice, issued by the International Journal of Neuropsychopharmacology:
The National Institutes of Health has found that Dr. Jagadeesh S. Rao engaged in research misconduct by falsifying data in “Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients, Jagadeesh S. Rao, Stanley I. Rapoport and Hyung-Wook Kim, Int. J. Neuropsychopharmacology 12: 851–860, 2009.” Data in Figures 1A, 1B, 2A and 2B were falsified. Dr. Rao was solely responsible for the falsification. None of the other authors are implicated in any way.
“Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients” has been cited 13 times since it was published in 2009.
Here are two additional retractions, both from the Journal of Neurochemistry. Both cite each other, along with an investigation at the National Institutes of Health:
The above article from Journal of Neurochemistry, published online on 13 April 2007 in Wiley Online Library (wileyonlinelibrary.com) and in volume 102, issue 6, pp. 1918−1927, has been retracted by agreement between the corresponding author Stanley Rapoport, co-author Richard Bazinet, the Journal’s Editor-in-Chief Jörg Schulz, and John Wiley & Sons Ltd.
The Editorial Office was contacted by the author Stanley Rapoport with the request to retract this and a related publication (see below), informing the Editor-in-Chief that the National Institutes of Health (NIH) had found Dr. Jagadeesh S. Rao guilty of research misconduct by falsifying data in the referenced paper. The Editorial Office was forwarded a letter signed by investigation committee members on behalf of NIH and NIA, which states:
“[…] The National Institutes of Health (NIH) investigated allegations of research misconduct involving the falsification of data in “Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2.” Jagadeesh S. Rao, Renee N. Ertley, Stanley I. Rapoport, Richard P. Bazinet, and Ho-Joo Lee. J. Neurochemistry 102, 1918−1927, 2007. Based on the unanimous decision of a five member committee, composed of NIH investigators, NIH found that Dr. Jagadeesh Rao, corresponding author, knowingly and intentionally committed research misconduct by falsifying data in Figures 3 and 5 in the manuscript listed above. Dr. Rao was solely responsible for the falsification and all other authors were uninvolved. The report was submitted to the HHS Office of Research Integrity for its review. Because Dr. Rao was the corresponding author, Dr. Stanley I. Rapoport, Senior Advisor for the former Laboratory of Brain Physiology and Metabolism Section, is acting for Dr. Rao, who was his representative, and approves this request to retract this publication using the recommended language, in italics above.”
A related paper has also been retracted:
Keleshian VL, Modi HR, Rapoport SI, Rao JS. (2013) Aging is associated with altered inflammatory, arachidonic acid cascade, and synaptic markers, influenced by epigenetic modifications, in the human frontal cortex. J. Neurochem. 125: 63−73.
“Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2” has been cited 44 times since it was published in 2007.
The second notice from the journal reads very similarly, noting that the investigative committee concluded that Rao had falsified data in Figures 1A, 1G, 3G, and 4D of the paper. “Aging is associated with altered inflammatory, arachidonic acid cascade, and synaptic markers, influenced by epigenetic modifications, in the human frontal cortex” has been cited 19 times since it appeared in 2013.
Late last year, Rapoport told us that more retractions of papers co-authored by Rao were in the works.
In a story we posted last December, Rapoport shared his reaction to multiple cases of misconduct by his colleagues, including the two first authors we’ve already reported on, Fei Gao and Mireille Basselin:
The misconduct, as I now understand it, was very technical and outside of my areas of expertise. In retrospect, I don’t think I could have spotted the misconduct earlier. Data were presented at internal meetings, when the misconduct was not identified. Basselin and Gao and Rao had PhDs and strong letters of recommendation.
In these days of complex interdisciplinary research, one depends on the trustworthiness of colleagues who use methodologies with which one has no personal experience. I regret missing the falsifications by Dr. Rao…
Hat tip: Rolf Degen
Like Retraction Watch? Consider making a tax-deductible contribution to support our growth. You can also follow us on Twitter, like us on Facebook, add us to your RSS reader, sign up on our homepage for an email every time there’s a new post, or subscribe to our daily digest. Click here to review our Comments Policy. For a sneak peek at what we’re working on, click here.